NRx Pharmaceuticals Files Provisional Patent for Stable Comp

Press release content from PR Newswire. The AP news staff was not involved in its creation.

Related Keywords

United States , Israel , Daniele Troy , Eric Goldstein , Jack Hirschfield , Chaim Hurvitz , Sherry Glied , Jonathan Javitt , Nrx Pharmaceuticals , Phd Us Army , Israel Ministry Of Defense , Novartis , Pfizer , Trademark Office , Prnewswire Nrx Pharmaceuticals Nasdaq , Source Nrx Pharmaceuticals , Allergan , Us Department Of Health , Israel Institute For Biological Research , Biomedical Advanced Research , Human Services , Drug Administration , United States National Security Advisor , Development Authority , Nrx Pharmaceuticals Inc , Nephron Pharmaceuticals , Teva International Group , Us Department Of Defense , Head Of Corporate Communications , Us National Institutes Of Health , Buffer Free Compositions , Vasoactive Intestinal Peptide , Prof Jonathan Javitt , Israel Institute , Biological Research , Israel Ministry , Fast Track , Medical Countermeasures , Breakthrough Therapy Designation , Special Protocol Agreement , Biomarker Letter , Chief Counsel , United States National Security , Vasoactive Intestinal Polypeptide , Sami Said , Securities Litigation Reform Act , Corporate Communications , Coronavirus Pandemic , Business , Health , Pr Newswire , Patents ,